AR075428A1 - Formulacion de doramectina en dosis elevada - Google Patents
Formulacion de doramectina en dosis elevadaInfo
- Publication number
- AR075428A1 AR075428A1 ARP100100431A ARP100100431A AR075428A1 AR 075428 A1 AR075428 A1 AR 075428A1 AR P100100431 A ARP100100431 A AR P100100431A AR P100100431 A ARP100100431 A AR P100100431A AR 075428 A1 AR075428 A1 AR 075428A1
- Authority
- AR
- Argentina
- Prior art keywords
- vitamin
- fat
- group
- antiparasitic
- veterinary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Reivindicacion 1: Composicion veterinaria antiparasitaria que comprende a) doramectina al 3-6% p/v, b) aceite de algodon al 39-60% v/v, c) benzoato de bencilo al 30-50% v/v; y opcionalmente d) uno o más entre conservante, excipiente auxiliar y vitamina liposoluble. Reivindicacion 4: Composicion segun la reivindicacion 3, que comprende adicionalmente una o más vitaminas liposolubles seleccionadas del grupo que consiste en vitamina A, vitamina D y vitamina E. Reivindicacion 8: Utilizacion de la composicion segun una cualquiera de las reivindicaciones 1 a 7 para preparar un medicamento para la prevencion, tratamiento o control de parásitos en el ganado, que comprende la administracion por vía parenteral de dicho medicamento a dicho animal. Reivindicacion 10: Composicion veterinaria politerápica antiparasitaria que comprende a) doramectina al 1-3% p/v, b) agente antiparasitario al 1-3% p/v o combinacion al 1-3% p/v de más de un agente antiparasitario seleccionado del grupo que consiste en abamectina, ivermectina, eprinomectina, moxidectina y milbemicina, c) aceite de algodon al 39-75% v/v, d) benzoato de bencilo al 25-50% v/v; y opcionalmente e) uno o más entre un conservante, excipiente auxiliar y vitamina liposoluble, en la que dicha vitamina se selecciona del grupo que consiste en vitamina A, vitamina D y vitamina E.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15291109P | 2009-02-16 | 2009-02-16 | |
| US21983709P | 2009-06-24 | 2009-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR075428A1 true AR075428A1 (es) | 2011-03-30 |
Family
ID=42060687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100100431A AR075428A1 (es) | 2009-02-16 | 2010-02-15 | Formulacion de doramectina en dosis elevada |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8551962B2 (es) |
| EP (1) | EP2396006B1 (es) |
| JP (1) | JP2012517994A (es) |
| KR (1) | KR101326428B1 (es) |
| CN (1) | CN102316876B (es) |
| AR (1) | AR075428A1 (es) |
| AU (1) | AU2010233409B2 (es) |
| BR (1) | BRPI1008822B1 (es) |
| CA (1) | CA2750626C (es) |
| CL (1) | CL2011001775A1 (es) |
| CO (1) | CO6410307A2 (es) |
| DK (1) | DK2396006T3 (es) |
| ES (1) | ES2399228T3 (es) |
| HK (1) | HK1161087A1 (es) |
| MX (1) | MX2011008614A (es) |
| NZ (1) | NZ594389A (es) |
| PL (1) | PL2396006T3 (es) |
| PT (1) | PT2396006E (es) |
| WO (1) | WO2010116267A1 (es) |
| ZA (1) | ZA201105310B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9616044B2 (en) | 2012-03-13 | 2017-04-11 | Bayer New Zealand Ltd | Long acting compositions |
| ES2436249B1 (es) * | 2012-06-25 | 2014-06-23 | Javier Alberto ALONSO-VAQUERO VELASCO | Composición antiparasitaria para el control y tratamiento de parásitos de diferentes especies animales, caracterizada por combinar Moxidectina con las vitaminas: A, D3, y E |
| WO2014098623A1 (en) * | 2012-12-20 | 2014-06-26 | Alleva Animal Health Limited | Injectable eprinomectin formulation and anthelmintic use thereof |
| CN103977017B (zh) * | 2014-06-03 | 2016-09-07 | 重庆布尔动物药业有限公司 | 一种兽用抗寄生虫注射液及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8800986A1 (es) | 1985-07-27 | 1987-12-01 | Pfizer | Un procedimiento para la produccion de un nuevo derivado de avermectina |
| US6001822A (en) | 1989-04-11 | 1999-12-14 | Pfizer Inc. | Antiparasitic formulations |
| ES2052173T3 (es) | 1989-04-11 | 1994-07-01 | Pfizer | Composiciones inyectables que contienen 25-cyclohexil-avermectina b1. |
| WO1997011709A1 (en) * | 1995-09-25 | 1997-04-03 | Ashmont Holdings Limited | Anthelmintic macrocyclic lactone compositions |
| DE19613972A1 (de) | 1996-04-09 | 1997-10-16 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl |
| AU728221B2 (en) | 1996-06-05 | 2001-01-04 | Ashmont Holdings Limited | Injectable compositions |
| DE19638045A1 (de) * | 1996-09-18 | 1998-03-19 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen |
| US6174540B1 (en) | 1998-09-14 | 2001-01-16 | Merck & Co., Inc. | Long acting injectable formulations containing hydrogenated caster oil |
| KR20000025762A (ko) * | 1998-10-14 | 2000-05-06 | 유충식 | 이버멕틴류의 가용화 조성물 |
| GB9825402D0 (en) * | 1998-11-19 | 1999-01-13 | Pfizer Ltd | Antiparasitic formulations |
| GB9827727D0 (en) | 1998-12-16 | 1999-02-10 | Pfizer Ltd | Antiparasitic formulations |
| CN1304727A (zh) * | 2000-10-20 | 2001-07-25 | 王玉万 | 一种以苯甲酸苄酯或氮酮为助溶剂的含阿维菌素或伊维菌素的注射液 |
-
2010
- 2010-02-02 PL PL10703519T patent/PL2396006T3/pl unknown
- 2010-02-02 AU AU2010233409A patent/AU2010233409B2/en active Active
- 2010-02-02 WO PCT/IB2010/050443 patent/WO2010116267A1/en active Application Filing
- 2010-02-02 CA CA2750626A patent/CA2750626C/en not_active Expired - Fee Related
- 2010-02-02 BR BRPI1008822-9A patent/BRPI1008822B1/pt active IP Right Grant
- 2010-02-02 KR KR1020117021507A patent/KR101326428B1/ko not_active IP Right Cessation
- 2010-02-02 ES ES10703519T patent/ES2399228T3/es active Active
- 2010-02-02 CN CN2010800079297A patent/CN102316876B/zh active Active
- 2010-02-02 DK DK10703519.8T patent/DK2396006T3/da active
- 2010-02-02 EP EP10703519A patent/EP2396006B1/en not_active Not-in-force
- 2010-02-02 PT PT107035198T patent/PT2396006E/pt unknown
- 2010-02-02 NZ NZ594389A patent/NZ594389A/xx not_active IP Right Cessation
- 2010-02-02 MX MX2011008614A patent/MX2011008614A/es active IP Right Grant
- 2010-02-02 JP JP2011549707A patent/JP2012517994A/ja active Pending
- 2010-02-02 US US13/147,600 patent/US8551962B2/en not_active Expired - Fee Related
- 2010-02-15 AR ARP100100431A patent/AR075428A1/es active IP Right Grant
-
2011
- 2011-07-19 ZA ZA2011/05310A patent/ZA201105310B/en unknown
- 2011-07-21 CL CL2011001775A patent/CL2011001775A1/es unknown
- 2011-08-30 CO CO11111108A patent/CO6410307A2/es not_active Application Discontinuation
-
2012
- 2012-02-16 HK HK12101546.3A patent/HK1161087A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2396006A1 (en) | 2011-12-21 |
| NZ594389A (en) | 2012-09-28 |
| ES2399228T3 (es) | 2013-03-26 |
| US20110294751A1 (en) | 2011-12-01 |
| PL2396006T3 (pl) | 2013-06-28 |
| KR20110116231A (ko) | 2011-10-25 |
| CA2750626A1 (en) | 2010-10-14 |
| US8551962B2 (en) | 2013-10-08 |
| HK1161087A1 (en) | 2012-08-24 |
| BRPI1008822B1 (pt) | 2019-04-09 |
| CN102316876B (zh) | 2013-07-17 |
| CO6410307A2 (es) | 2012-03-30 |
| CL2011001775A1 (es) | 2011-10-28 |
| DK2396006T3 (da) | 2013-02-11 |
| WO2010116267A1 (en) | 2010-10-14 |
| PT2396006E (pt) | 2013-02-13 |
| CA2750626C (en) | 2013-10-01 |
| AU2010233409B2 (en) | 2012-05-17 |
| AU2010233409A1 (en) | 2011-08-11 |
| EP2396006B1 (en) | 2012-12-19 |
| CN102316876A (zh) | 2012-01-11 |
| JP2012517994A (ja) | 2012-08-09 |
| KR101326428B1 (ko) | 2013-11-20 |
| ZA201105310B (en) | 2012-09-26 |
| MX2011008614A (es) | 2011-09-09 |
| BRPI1008822A2 (pt) | 2016-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020000739A1 (es) | Agente prolongado de control de ectoparasito para animales. | |
| CR7140A (es) | Antranilamidas con una cadena colateral de un heteroarylsulfonil, metodos para la produccion de los mismos, su uso como medicamento o agente diagnostico y preparaciones farmaceuticas contenidas en dichos compuestos | |
| BR112017021073A2 (pt) | composições injetáveis de liberação prolongada compreendendo um agente ativo de isoxazolina, seus métodos e usos | |
| BR112014019262A8 (pt) | Composições orais veterinárias parasíticas compreendendo ingredientes ativos de ação sistêmica, métodos e uso das mesmas | |
| CL2017002164A1 (es) | Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas | |
| AR057319A1 (es) | Composicion para la administracion topica y metodo para evitar o tratar infeccion o infestacion endoparasitica y ectoparasitica en un animal de sangre caliente | |
| ES2723779T3 (es) | Formulación para el control de piojos y garrapatas en el ganado | |
| AR075428A1 (es) | Formulacion de doramectina en dosis elevada | |
| UY28271A1 (es) | Compuestos químicos | |
| AR078860A1 (es) | Asociaciones farmaceuticas, composiciones farmaceuticas, medicamento y metodo para el tratamiento de animales | |
| RU2017138118A (ru) | Комбинации противоглистных агентов и способы их применения | |
| MX2016012319A (es) | Formulaciones antihelminticas veterinarias estables. | |
| ECSP066360A (es) | Composición parasiticida | |
| AR043824A1 (es) | Composiciones y metodo para tratar las infecciones microbianas y parasitarias en el ganado y otros animales | |
| EP1968585B1 (en) | Veterinarian composition for use as fasciolicide in animals | |
| PE20151726A1 (es) | Formulaciones veterinarias estables de combinacion de lactonas macrociclicas e imidazotiazoles | |
| UY38965A (es) | Composiciones que comprenden canabidiol y flavanonas | |
| AR081970A1 (es) | Formulacion inyectable de una lactona macrociclica y levamisol, formulacion y uso veterinario | |
| CO5190659A1 (es) | Sapogeninas esteroides para el control de coccidiosis en animales | |
| AR122059A1 (es) | Usos y formulaciones de cannabinoides | |
| GT200900295A (es) | Composición farmacéutica que comprende la combinación del agente antimicrobiano ciprofloxacino y el agente antioxidante ácido ascórbico para el tratamiento de infecciones urinarias. | |
| ES2436249B1 (es) | Composición antiparasitaria para el control y tratamiento de parásitos de diferentes especies animales, caracterizada por combinar Moxidectina con las vitaminas: A, D3, y E | |
| BR112021026471A2 (pt) | Formulações de dose sólida para a liberação sem agulha | |
| NZ619027A (en) | Transdermal parasiticidal formulations | |
| AR110598A1 (es) | Profármacos de principios activos citotóxicos con grupos enzimáticamente escindibles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |